| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.085 | 0.08 |